The absence of functional glucosylceramide synthase does not sensitize melanoma cells for anticancer drugs.

The FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Volumn 17, Issue 9, 2003, Pages 1144-1146

  Veldman, Robert Jan ^a   Mita, Alain ^a   Cuvillier, Olivier ^a   Garcia, Virginie ^a   Klappe, Karin ^a   Medin, Jeffrey A ^a   Campbell, John D ^a   Carpentier, Stéphane ^a   Kok, Jan Willem ^a   Levade, Thierry ^a  

^a CHU RANGUEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ANTINEOPLASTIC AGENT; CERAMIDE; CERAMIDE GLUCOSYLTRANSFERASE; DOXORUBICIN; GLUCOSYLTRANSFERASE;

ANIMAL; APOPTOSIS; ARTICLE; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL CULTURE; CELL SURVIVAL; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG RESISTANCE; ENZYMOLOGY; EXPERIMENTAL MELANOMA; GENE DELETION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MOUSE; PATHOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; ATP-BINDING CASSETTE TRANSPORTERS; CELL SURVIVAL; CERAMIDES; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; GENE DELETION; GLUCOSYLTRANSFERASES; MELANOMA, EXPERIMENTAL; MICE; MODELS, BIOLOGICAL; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0038380478     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.02-1053fje     Document Type: Article

References (0)